InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Egan Dwight H, Chairman & CEO. Director active across 2 companies, notably Co-Diagnostics, Inc.. Cumulatively, 5 reports have been published. The latest transaction was disclosed on 23 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
033,334 shares0
Common Stock
SEC:0001562180-22-004379:0·
033,333 shares0
Common Stock
SEC:0001562180-21-007256·
033,333 shares0
Common Stock
SEC:0001562180-21-007256:0·
012,500 shares0
Common Stock
SEC:0001562180-21-003741·
012,500 shares0
Common Stock
SEC:0001562180-21-003741:0·
5 of 5 declarations
About Egan Dwight H
Dwight H. Egan is the Chief Executive Officer at Co-Diagnostics, Inc. In this role, he is responsible for the strategic and operational direction of the company. Egan plays a key role in making decisions that influence the future direction of the organization. His expertise in biotechnology and management is essential for the success of the company.
